Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AVNR > SEC Filings for AVNR > Form 8-K on 7-May-2014All Recent SEC Filings

Show all filings for AVANIR PHARMACEUTICALS, INC.

Form 8-K for AVANIR PHARMACEUTICALS, INC.


7-May-2014

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.

On May 7, 2014, Avanir Pharmaceuticals, Inc. (the "Company") entered into a third amendment (the "Third Amendment") to the Sales Agreement dated August 8, 2012 as amended July 5, 2013 and as subsequently amended on December 10, 2013 (the "Sales Agreement") with Cowen and Company, LLC relating to the sale of an additional $50,000,000 of shares of the Company's common stock, $0.0001 par value per share.

A copy of the Sales Agreement was filed as an exhibit to the Company's Registration Statement on Form S-3 (File No. 333-183153) filed on August 8, 2012. A copy of the first amendment was filed as an exhibit to the Company's Registration Statement on Form S-3 (File No. 333-189831) filed on July 5, 2013. A copy of the second amendment was filed as an exhibit to the Company's Current Report on Form 8-K filed on December 10, 2013. A copy of the Third Amendment is filed herewith as Exhibit 1.1. A copy of the opinion of Gibson, Dunn & Crutcher LLP relating to the validity of the shares to be sold pursuant to the Sales Agreement, as amended by the Third Amendment, is filed herewith as Exhibit 5.1.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No. Description

1.1 Third Amendment to Sales Agreement, dated May 7, 2014

5.1 Opinion of Gibson, Dunn & Crutcher LLP


  Add AVNR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AVNR - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.